Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) ยท filed Jan 27, 2022
- Accession no.
- 0001209191-22-005138
- Filed
- Jan 27, 2022, 8:12 AM ET
- Trade date
- Jan 26, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 17 non-derivative transactions. Open-market purchases total $1.04M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +900 | $2.92 | +$2,623.5 | 193,172,594 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +12,100 | $2.92 | +$35,319.9 | 193,184,694 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +27,357 | $2.92 | +$79,882.44 | 193,212,051 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +600 | $2.93 | +$1,755 | 193,212,651 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +34,043 | $2.93 | +$99,745.99 | 193,246,694 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $2.96 | +$59,200 | 193,266,694 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +20,600 | $2.97 | +$61,182 | 193,287,294 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +14,800 | $2.98 | +$44,030 | 193,302,094 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +10,300 | $2.98 | +$30,694 | 193,312,394 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +11,300 | $2.99 | +$33,730.5 | 193,323,694 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +16,600 | $2.99 | +$49,617.4 | 193,340,294 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $2.99 | +$14,947 | 193,345,294 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +50,874 | $2.99 | +$152,113.26 | 193,396,168 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +200 | $3.00 | +$599 | 193,396,368 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +85,326 | $3.00 | +$255,978 | 193,481,694 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +100 | $3.01 | +$300.5 | 193,481,794 | Indirect | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +39,900 | $3.01 | +$120,099 | 193,521,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.